Niva Bupa Health Insurance Company Limited reported its Q1 FY2026 results with total income of ₹1,308 crores and a net loss of ₹91 crores for the quarter ended June 30, 2025. The company experienced a sequential revenue decline of 16.4% from ₹1,565 crores in Q4 FY2025, while moving from a profit of ₹206 crores in the previous quarter to a loss of ₹91 crores, representing a significant deterioration in profitability. Compared to the corresponding quarter last year, revenue grew by 12.8% from ₹1,159 crores, but the loss widened substantially from ₹19 crores in Q1 FY2025, indicating mounting operational challenges.

Niva Bupa Health Insurance Company Limited, formerly Max Bupa Health Insurance, is one of India’s leading standalone health insurers with IRDAI registration number 145. The company was established in 2008 and went public in November 2024, listing on both NSE and BSE with its shares trading under the symbol NIVABUPA. Specializing in comprehensive health insurance solutions, Niva Bupa offers individual, family, and group health insurance products across India, focusing on cashless hospitalization, preventive healthcare, and digital-first customer experience through its extensive network of hospitals and healthcare providers.